Tag: M.W:300-400

Reference of 1034305-11-7, Research speed reading in 2021. The prevalence of solvent effects in heterogeneous catalysis in condensed media has motivated developing quantitative theoretical assessments of solvent structures. In a article, 1034305-11-7, molcular formula is C15H10BrFOS, introducing its new discovery.

The invention discloses a 2 – (5 – bromo – 2 – fluorobenzyl) benzo thiophene synthetic method, in order to 2 – fluoro – 5 – bromobenzene as a raw material, under the action of alkali through condensation and reduction shall be the target compound, comprising a condensation reaction and the reduction reaction, the present invention only two-step reaction to obtain the target compound, reduces the material varieties, improving the operating efficiency. The present invention not using a boron trifluoride ether and other chemicals, and does not use the like sodium borohydride as the reducing agent is not suitable for industrial scale, without the need for ultra-low temperature thereby reducing the production cost, in short synthetic method of this invention has mild reaction condition, simple process operation, environmental protection, low cost, and high yield. (by machine translation)

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Reference of 1034305-11-7. In my other articles, you can also check out more blogs about 1034305-11-7

Reference：
Benzothiophene – Wikipedia,
Benzothiophene | C8H6S – PubChem

Related Products of 84449-65-0, Chemical Research Letters, May 2021. As an important bridge between the micro and macro material world, chemistry is one of the main methods and means for humans to understand and transform the material world. In a article, 84449-65-0, molcular formula is C16H14O6S3, introducing its new discovery.

The invention is a compound of Formula (I): whereinR is ?OH,R1 is ?OH,R2 is ?H,n is 2 or 3 andX is sulfur, ora pharmaceutically acceptable salt of a compound having Formula (1), ora pharmaceutical composition comprising a compound having Formula (1) or a pharmaceutically acceptable salt thereof, ormethods of treating bone loss, breast cancer or prostate cancer comprising administering an effective amount of the compound having Formula (I) or a pharmaceutically acceptable salt thereof.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Related Products of 84449-65-0. In my other articles, you can also check out more blogs about 84449-65-0

Reference：
Benzothiophene – Wikipedia,
Benzothiophene | C8H6S – PubChem

Related Products of 1034305-17-3, Chemical Research Letters, May 2021. This type of reactivity has quickly become one of the cornerstones of modern catalysis . In a article, 1034305-17-3, molcular formula is C15H10BrFS, introducing its new discovery.

The subject of this invention is to provide a high efficiency and industrial conditions in order to facilitate manufacturing C-glycoside derivative technology. Use of the aryl magnesium acid salt (aryl magnesate) the coupling reaction, thereby can prevent the ultra-low temperature reaction, and at the same time, can be short time and high-yield manufacturing C-glycoside derivative. (by machine translation)

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Related Products of 1034305-17-3. In my other articles, you can also check out more blogs about 1034305-17-3

Reference：
Benzothiophene – Wikipedia,
Benzothiophene | C8H6S – PubChem

The dynamic chemical diversity of the numerous elements, ions and molecules that constitute the basis of life provides wide challenges and opportunities for research. Computed Properties of C15H10BrFOS, In an article, mentioned the application of 1034305-11-7, Name is Benzo[b]thiophen-2-yl(5-bromo-2-fluorophenyl)methanol, molecular formula is C15H10BrFOS

The present invention provides a method for producing a C-glycoside derivative, which can produce the C-glycoside derivative at a high yield and at a low cost, which conforms to environmental protection, and which is applicable industrially. The C-glycoside derivative is useful for treating and preventing diabetes such as insulin-dependent diabetes (type 1 diabetes), non-insulin-dependent diabetes (type 2 diabetes) and the like and various diabetes-related diseases including insulin-resistant diseases and obesity.

Keep reading other articles of 1034305-11-7, Computed Properties of C15H10BrFOS, Don’t worry, you don’t need a PhD in chemistry to understand the explanations!

Reference：
Benzothiophene – Wikipedia,
Benzothiophene | C8H6S – PubChem

Enzyme inhibitors cause a decrease in the reaction rate of an enzyme-catalyzed reaction by binding to a specific portion of an enzyme and thus slowing or preventing a reaction from occurring. Recommanded Product: 2-(5-Bromo-2-fluorobenzyl)benzo[b]thiophene, C15H10BrFS. A document type is Patent, introducing its new discovery., Recommanded Product: 2-(5-Bromo-2-fluorobenzyl)benzo[b]thiophene

The invention discloses the Iraqi gliclazide net intermediate preparation method, including 2 – (3 – benzo [B] thiophene – 2 – yl methyl – 4 – fluoro – phenyl) – 3, 4, 5 – c – trimethyl siloxy – 6 – trimethyl siloxy methyl – tetrahydro – pyran – 2 – ol (compound 3) and (1 S) – 2, 3, 4, 6 – four-acetoxy – 1, 5 – dehydration – 1 – [3 – (1 – benzothiophene – 2 – yl methyl) – 4 – fluorophenyl] – D – sorbitol (compound 6) specific preparation method; wherein the control of the reaction temperature not higher than – 60 C under the premise, as soon as possible should be adds by drops positively BuLi, n-butyl and the faster the dropping speed, compound 3 of ortho-substituted F of less by-products, to ensure that the resulting compound 3 of purity, and had a direct impact on the resulting compound 6 yield, the present invention is amplified without amplifying effect, it is suitable for industrial production. (by machine translation)

You can also check out more blogs about 1034305-17-3

Reference：
Benzothiophene – Wikipedia,
Benzothiophene | C8H6S – PubChem

New Advances in Chemical Research, May 2021. The prevalence of solvent effects in heterogeneous catalysis in condensed media has motivated developing quantitative kinetic, and theoretical assessments of solvent structures and transition states. Formula: C15H10BrFOS, C15H10BrFOS. A document type is Article, introducing its new discovery., Formula: C15H10BrFOS

A series of C-glucosides with various heteroaromatics has been synthesized and its inhibitory activity toward SGLTs was evaluated. Upon screening several compounds, the benzothiophene derivative (14a) was found to have potent inhibitory activity against SGLT2 and good selectivity versus SGLT1. Through further optimization of 14a, a novel benzothiophene derivative (14h; ipragliflozin, ASP1941) was discovered as a highly potent and selective SGLT2 inhibitor that reduced blood glucose levels in a dose-dependent manner in diabetic models KK-Ay mice and STZ rats.

We very much hope you enjoy reading the articles and that you will join us to present your own research about 1034305-11-7, Formula: C15H10BrFOS

Reference：
Benzothiophene – Wikipedia,
Benzothiophene | C8H6S – PubChem

New Advances in Chemical Research, May 2021. The prevalence of solvent effects in heterogeneous catalysis in condensed media has motivated developing quantitative kinetic, and theoretical assessments of solvent structures and transition states. HPLC of Formula: C16H14O6S3, C16H14O6S3. A document type is Patent, introducing its new discovery., HPLC of Formula: C16H14O6S3

6-Hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]benzo[b]thiophene, its ethers and esters, and the physiologically acceptable acid addition salts thereof, are valuable antiestrogens and antiendrogens.

This is the end of this tutorial post, and I hope it has helped your research about 84449-65-0 .HPLC of Formula: C16H14O6S3

Reference：
Benzothiophene – Wikipedia,
Benzothiophene | C8H6S – PubChem

84449-65-0, Research speed reading in 2021. The prevalence of solvent effects in heterogeneous catalysis in condensed media has motivated developing quantitative theoretical assessments of solvent structures. In a article, 84449-65-0, molcular formula is C16H14O6S3, introducing its new discovery.

In an effort to prepare nonsteroidal antiestrogens demonstrating greater antagonism and less intrinsic estrogenicity than those currently available, a series of 3-aroyl-2-arylbenzothiophene derivatives was synthesized.These compounds were prepared by Friedel-Crafts aroylation of appropriate O-protected 2-arylbenzothiophene nuclei with basic side-chain-bearing benzoyl chlorides followed by removal of the protective groups to provide the desired compounds containing both hydroxyl and basic side-chain functionality.A particularly useful method for the cleavage of aryl methoxy ethers without removal of (dialkylamino)ethoxy side chain functionality elsewhere in the molecule was found to be AlCl3/EtSH.The benzothiophene derivatives were tested for their ability to inhibit the growth-stimulating action of estradiol on the immature rat uterus.Seemingly minor changes in the side-chain amine moiety were found to have profound effects on the ability of the compounds to antagonize estradiol.Analogues having basic side chains containing cyclic (pyrrolidine, piperidine, and hexamethyleneamine) moieties were found to have less intrinsic estrogenicity and to antagonize estradiol action more completely than their noncyclic counterparts.The most effective antiestrogen in the series, compound 44, <6-hydroxy-2-(4-hydroxyphenyl)benzothien-3-yl><4-<2-(1-piperidinyl)ethoxy>phenyl>methanone, elicited a modest uterotropic activity that did not increase with increasing dose.In antagonism of estradiol, 44 exhibited a degree of inhibition surpassing that of tamoxifen at any dose tested.The new benzothiophene antiestrogen was also shown to have high affinity for rat uterine cycloplasmic estrogen receptor and to be an inhibitor of the growth of DMBA-induced rat mammary tumors.